期刊文献+

清金化痰汤联合抗感染药物治疗肺部感染的临床效果观察

Clinical Observation of Qingjin Huayu Decoction Combined with Anti-infective Drugs in Treating Pulmonary Infection
下载PDF
导出
摘要 目的探讨清金化痰汤联合抗感染药物治疗肺部感染的临床效果。方法选取本院于2015年10月至2017年8月收治的64例肺部感染患者,按随机数字表法分为2组,每组32例,对照组采用抗感染药物治疗,观察组则在此基础上,联合中药清金化痰汤治疗,对比两组临床疗效、症状消失时间及不良反应情况。结果观察组治疗总有效率(93.75%)明显高于对照组(75.00%),两组比较差异显著(P<0.05);观察组肺部啰音、咯痰、喘息、咳嗽及发热消失时间相比对照组,均明显短于后者(P<0.05)。两组不良反应发生率比较,差异不明显(P>0.05)。结论针对肺部感染患者,采用清金化痰汤与抗感染药物联合施治,疗效好,症状消失时间短,安全可靠,临床应用价值高。 Objective To investigate the clinical effect of Qingjin Huayu Decoction combined with anti-infective drugs in the treatment of pulmonary infection. Methods Sixty-four patients with pulmonary infection admitted to our hospital from October 2015 to August 2017 were randomly divided into two groups, 32 in each group. The control group was treated with anti-infective drugs, while the observation group was in the observation group. On this basis, combined with Chinese medicine qingjin huayu decoction, the clinical efficacy, disappearance time and adverse reactions of the two groups were compared. Results The total effective rate of the observation group(93.75%) was significantly higher than that of the control group(75.00%). The difference between the two groups was significant(P< 0.05). The disappearance time of lung vocal, sputum, wheezing, cough and fever in the observation group was significantly shorter than that in the control group(P<0.05). The incidence of adverse reactions was not significantly different between the two groups(P> 0.05). Conclusion For patients with pulmonary infection, the combination of qingjin huayu decoction and anti-infective drugs has good curative effect, short symptom disappearing time, safe and reliable, and high clinical application value.
作者 陆乔 LU Qiao(Department of Respiratory Medicine,Guangzhou University of Chinese Medicine Qifu Hospital,Guangzhou,Guangdong,510000)
出处 《智慧健康》 2019年第6期106-108,共3页 Smart Healthcare
关键词 清金化痰汤 肺部感染 不良反应 Qingjin huayu decoction Pulmonary infection Adverse reactions
  • 相关文献

参考文献5

二级参考文献51

  • 1李海宏.痰热清注射液治疗术后并发坠积性肺炎疗效观察[J].中国医药导报,2005,2(14). 被引量:14
  • 2高益民,王忠山.对痰热清注射液临床药学初步评价[J].首都医药,2004,11(12):44-46. 被引量:205
  • 3付笑飞,姚尚龙.异丙托溴铵的药理基础及临床应用现状[J].华中医学杂志,2005,29(2):139-140. 被引量:29
  • 4中风病诊断与疗效评定标准(试行)[J].北京中医药大学学报,1996,19(1):55-56. 被引量:5956
  • 5薛东升,李小利,宋庆宏.痰热清注射液作用机理与临床应用[J].上海医药,2007,28(11):521-522. 被引量:116
  • 6Wang PL, Zhao XQ, Du WL, et al. In hospital medical complications associated with patient dependency a{ter acute ischemic stroke:data from the China National Stroke Registry [J]. Chin Med J ( English version), 2013, 126 (7) : 225-228. DOI:10. 3760/cma.j.issn.0366-6999. 20122573.
  • 7Torres A, EI-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia [J]. Chest, 2000, 174 (4 Suppl 2) : 198S-202S. DOI: 10. 3760/cma. j. issn. 0578-1426. 2011.03. 004.
  • 8Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. [J]. Stroke, 2013, 34 (4): 589-591. DOI:10. 1161/01.STR.0000063373. 70993.CD.
  • 9Yamaguchi T,Nakanishi T,Hayashi M,et al.Efficacy and safety of cisplatin plus pemetrexed as a first-line treatment for Japanese patients with advanced non-squamous non-small-cell lung cancer a retrospective analysis[J].Gan To Kagaku Ryoho,2015,42(2):183-187.
  • 10Cheng XP,Wang BR,Liu HL,et al.Phosphorylation of extracellular signal-regulated kinases 1/2is predominantly enhanced in the microglia of the rat spinal cord following dorsal root transaction[J].Neuroscience,2003,119(3):701-712.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部